Related references
Note: Only part of the references are listed.Targeting CDK4 and CDK6 in cancer
Shom Goel et al.
NATURE REVIEWS CANCER (2022)
ZEB1 induces non-small cell lung cancer development by targeting microRNA-320a to increase the expression of RAD51AP1
Huifeng Wang et al.
EXPERIMENTAL CELL RESEARCH (2021)
SKA3, negatively regulated by miR-128-3p, promotes the progression of non-small-cell lung cancer
Linlin Xie et al.
PERSONALIZED MEDICINE (2021)
SKA3 promotes lung adenocarcinoma metastasis through the EGFR PI3K-Akt axis
Dan-dan Hu et al.
BIOSCIENCE REPORTS (2020)
miR-593-5p inhibit cell proliferation by targeting PLK1 in non small cell lung cancer cells
Liang Yan et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1
Asa Ehlen et al.
NATURE COMMUNICATIONS (2020)
Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis
Wei Gao et al.
CELL DEATH & DISEASE (2020)
SKA3 Promotes Cell Growth in Breast Cancer by Inhibiting PLK-1 Protein Degradation
Li-wei Ruan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair
Weizhe Li et al.
SCIENCE ADVANCES (2019)
Lung Cancer
Faria Nasim et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma
Yuchen Hou et al.
CELL DEATH & DISEASE (2019)
SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway
Rong Hu et al.
CANCER CELL INTERNATIONAL (2018)
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment
Gurkan Mollaoglu et al.
IMMUNITY (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Playing polo during mitosis: PLK1 takes the lead
G. Combes et al.
ONCOGENE (2017)
PLK1, A Potential Target for Cancer Therapy
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2017)
MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
Kai Qu et al.
CELL DEATH & DISEASE (2017)
Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1
Tonghai Huang et al.
DNA AND CELL BIOLOGY (2017)
Ska3 Phosphorylated by Cdk1 Binds Ndc80 and Recruits Ska to Kinetochores to Promote Mitotic Progression
Qian Zhang et al.
CURRENT BIOLOGY (2017)
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
Jill E. Larsen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Rosie Elizabeth Ann Gutteridge et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore
Emily A. Foley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death
D. S. O'Donovan et al.
CELL DEATH & DISEASE (2013)
Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer
Ling-Min Kong et al.
CANCER SCIENCE (2010)
Plk1 regulates liver tumor cell death by phosphorylation of TAp63
S. Komatsu et al.
ONCOGENE (2009)
Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance
Zhao Zhi-hong et al.
CHINESE MEDICAL JOURNAL (2008)
Share Paper
